Literature DB >> 27000516

A systematic review of the risks factors associated with the onset and natural progression of hydrocephalus.

Stephanie Walsh1, Jennifer Donnan2, Andrea Morrissey3, Lindsey Sikora4, Sonya Bowen3, Kayla Collins3, Don MacDonald3.   

Abstract

The purpose of this study was to systematically assess and synthesize the world literature on risk factors for the onset and natural progression of hydrocephalus, thereby providing a basis for policy makers to identify appropriate risk management measures to mitigate the burden of disease in Canada. Evidence for risk factors was limited for both onset and progression. Two meta-analyses that examined a risk factor for onset met the inclusion criteria. One found a significant protective effect of prenatal vitamins among case control studies, but not cohort/randomized controlled trials (RCTs). The second found maternal obesity to be a significant risk factor for congenital hydrocephalus. Significant risk factors among 25 observational studies included: biological (multiple births, maternal parity, common cold with fever, maternal thyroid disease, family history, preterm birth, hypertension, ischemic heart disease, ischemic ECG changes, higher cerebrospinal fluid protein concentration following vestibular schwannoma); lifestyle (maternal obesity, high-density lipoprotein (HDL) cholesterol, maternal diabetes, maternal age), healthcare-related (caesarean section, interhospital transfer, drainage duration following subarachnoid hemorrhage, proximity to midline for craniectomy following traumatic brain injury); pharmaceutical (prenatal exposure to: tribenoside, metronidazole, anesthesia, opioids); and environmental (altitude, paternal occupation). Three studies reported on genetic risk factors: no significant associations were found. There are major gaps in the literature with respect to risk factors for the natural progression of hydrocephalus. Only two observational studies were included and three factors reported. Many risk factors for the onset of hydrocephalus have been studied; for most, evidence remains limited or inconclusive. More work is needed to confirm any causal associations and better inform policy.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Etiology; Hydrocephalus; Onset; Progression; Risk factors; Systematic review

Mesh:

Year:  2016        PMID: 27000516     DOI: 10.1016/j.neuro.2016.03.012

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  3 in total

1.  Analysis of early neonatal case fatality rate among newborns with congenital hydrocephalus, a 2000-2014 multi-country registry-based study.

Authors:  Juan Antonio Gili; Jorge Santiago López-Camelo; Wendy N Nembhard; Marian Bakker; Hermien E K de Walle; Erin B Stallings; Vijaya Kancherla; Paolo Contiero; Saeed Dastgiri; Marcia L Feldkamp; Amy Nance; Miriam Gatt; Laura Martínez; María Aurora Canessa; Boris Groisman; Paula Hurtado-Villa; Karin Källén; Danielle Landau; Nathalie Lelong; Margery Morgan; Jazmín Arteaga-Vázquez; Anna Pierini; Anke Rissmann; Antonin Sipek; Elena Szabova; Wladimir Wertelecki; Ignacio Zarante; Mark A Canfield; Pierpaolo Mastroiacovo
Journal:  Birth Defects Res       Date:  2022-05-28       Impact factor: 2.661

2.  Prevalence and trend of isolated and complicated congenital hydrocephalus and preventive effect of folic acid in northern China, 2005-2015.

Authors:  Jufen Liu; Lei Jin; Zhiwen Li; Yali Zhang; Le Zhang; Linlin Wang; Aiguo Ren
Journal:  Metab Brain Dis       Date:  2018-02-01       Impact factor: 3.584

3.  Impacts of the COVID-19 Pandemic on the Healthcare Provision and Lived Experiences of Patients with Hydrocephalus.

Authors:  Diana F Pricop; Arsenije Subotic; Beatrice A M Anghelescu; Matthew Eagles; Mark Hamilton; Pamela Roach
Journal:  J Patient Exp       Date:  2022-04-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.